PMCA2 mRNA levels are elevated in some breast cancer cell lines20, and a tissue microarray (TMA) study suggested that high expression of PMCA2 protein predicts poor survival in patients under 50 years of age, and is associated with HER2-positive disease19. This evidence concerns the gene ERBB2 and breast carcinoma.